Raymond James Financial Services Advisors’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-750
| Closed | -$37.1K | – | 3237 |
|
|
2023
Q1 | $37.1K | Buy |
+750
| New | +$37.1K | ﹤0.01% | 3136 |
|
|
2022
Q4 | – | Sell |
-763
| Closed | -$51K | – | 3214 |
|
|
2022
Q3 | $51K | Sell |
763
-20
| -3% | -$1.34K | ﹤0.01% | 3072 |
|
|
2022
Q2 | $32K | Sell |
783
-19
| -2% | -$777 | ﹤0.01% | 3104 |
|
|
2022
Q1 | $40K | Hold |
802
| – | – | ﹤0.01% | 3182 |
|
|
2021
Q4 | $48K | Sell |
802
-47
| -6% | -$2.81K | ﹤0.01% | 3170 |
|
|
2021
Q3 | $42K | Sell |
849
-16
| -2% | -$792 | ﹤0.01% | 3179 |
|
|
2021
Q2 | $49K | Sell |
865
-18
| -2% | -$1.02K | ﹤0.01% | 3183 |
|
|
2021
Q1 | $51K | Buy |
883
+92
| +12% | +$5.31K | ﹤0.01% | 3084 |
|
|
2020
Q4 | $54K | Buy |
+791
| New | +$54K | ﹤0.01% | 2896 |
|